Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Progressive Multiple Sclerosis and Neuromyelitis Optica
This study is currently recruiting participants.
Verified November 2012
by Shenzhen Beike Bio-Technology Co., Ltd.
Study NCT01364246 Information provided by Shenzhen Beike Bio-Technology Co., Ltd.
First Received on May 31, 2011. Last Updated on November 26, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Progressive Multiple Sclerosis
Additional conditions recognized in this trial
More general conditions related to this trial
Autoimmune Diseases of the Nervous System
Cranial Nerve Diseases
Demyelinating Autoimmune Diseases, CNS
Immune System Diseases
Nervous System Diseases
Optic Nerve Diseases
Sponsors listed in this trial
Shenzhen Beike Bio-Technology Co., Ltd.
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
The Affiliated Nanjing Brain Hospital of Nanjing University Medical School
Nanjing University Medical College Affiliated Wuxi Second Hospital
Affiliated Hospital of Xuzhou Medical College
The Second Hospital of Nanjing Medical University
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers